In vivo imaging of inhibitory, GABAergic neurons by MRI

NeuroImage

Volumn 62, Issue 3, 2012, Pages 1685-1693

  Aswendt, Markus ^a   Gianolio, Eliana ^b   Pariani, Giorgio ^b   Napolitano, Roberta ^b   Fedeli, Franco ^b   Himmelreich, Uwe ^c   Aime, Silvio ^b   Hoehn, Mathias ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Glutamic acid decarboxylase; In vivo MRI of GABAergic neurons; Responsive MRI contrast agent; Stem cell differentiation protocol for GABAergic neurons

Indexed keywords

1 [5 [[N,N' BIS (3,10,17 TRIAZA 4,11,18 TRIOXO 21 CARBOXY 21 AMINOEINECOSANE)] N METHYLAMINOCARBONYL]PENTYL] 1,4,7,10 TETRAAZACYCLODODECANE 4,7,10 TRIACETATE (3) GADOLINATE; CONTRAST MEDIUM; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DECARBOXYLATION; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; BRAIN; BRAIN MAPPING; CONTRAST MEDIA; GABAERGIC NEURONS; GADOLINIUM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863518382     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.05.029     Document Type: Article

References (41)

1. Arena F., Singh J.B., Gianolio E., Stefanãa R., Aime S. beta-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing of a Gd(III) Containing probe forming a high relaxivity, melanin-like structure upon β-gal enzymatic activation. Bioconjug. Chem. 2011.
2. Arvidsson S., Kwasniewski M., Riano-Pachon D.M., Mueller-Roeber B. QuantPrime - a flexible tool for reliable high-throughput primer design for quantitative PCR. BMC Bioinformatics 2008, 9(1):465.
3. Benes F.M., Lim B., Matzilevich D., Walsh J.P., Subburaju S., Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10164-10169.
4. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 2003, 8(721-737):715.
5. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 1987, 7:2745-2752.
6. de Duve C., de Barsy T., Poole B., Trouet A., Tulkens P., Van Hoof F. Commentary. Lysosomotropic agents. Biochem. Pharmacol. 1974, 23:2495-2531.
7. Deng Y.P., Albin R.L., Penney J.B., Young A.B., Anderson K.D., Reiner A. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J. Chem. Neuroanat. 2004, 27:143-164.
8. Di Cristo G. Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin. Genet. 2007, 72:1-8.
9. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52:456-467.
10. Guenoun J., Koning G.A., Doeswijk G., Bosman L., Wielopolski P.A., Krestin G.P., Bernsen M.R. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI. Cell Transplant 2011, 21(1):191-205.
11. Himmelreich U., Dresselaers T. Cell labeling and tracking for experimental models using magnetic resonance imaging. Methods 2009, 48(2):112-124.
12. Himmelreich U., Aime S., Hieronymus T., Justicia C., Uggeri F., Zenke M., Hoehn M. A responsive MRI contrast agent to monitor functional cell status. Neuroimage 2006, 32:1142-1149.
13. Hoehn M., Himmelreich U. In vivo molecular MR imaging - potentials and limits. Annual Reports in NMR Spectroscopy - Handbook of Modern Magnetic Resonance, Section Medical Science 2006, 133-148. Kluwer Academic Publisher, London. G.A. Webb (Ed.).
14. Hoehn M., Himmelreich U., Kruttwig K., Wiedermann D. Molecular and cellular MR imaging: potentials and challenges for neurological applications. J. Magn. Reson. Imaging 2008, 27:941-954.
15. Kruttwig, K., 2009. Molecular labelling strategies for cellular optical and magnetic resonance tomographic visualisation. Aachen, Techn. Hochsch., Diss.
16. Kustermann E., Himmelreich U., Kandal K., Geelen T., Ketkar A., Wiedermann D., Strecker C., Esser J., Arnhold S., Hoehn M. Efficient stem cell labeling for MRI studies. Contrast Media Mol. Imaging 2008, 3:27-37.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
18. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 2000, 18:675-679.
19. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 2000, 18:321-325.
20. Malizia A.L., Cunningham V.J., Bell C.J., Liddle P.F., Jones T., Nutt D.J. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch. Gen. Psychiatry 1998, 55:715-720.
21. Moats R.A., Fraser S.E., Meade T.J. Ein "intelligentes" Reagens für die NMR-Bildgebung zur Bestimmung spezifischer enzymatischer Aktivität. Angew. Chem. Int. Ed. Engl. 1997, 36:726.
22. Modo M., Hoehn M., Bulte J.W. Cellular MR imaging. Mol. Imaging 2005, 4:143-164.
23. Mueller P.B., Langemann H. Distribution of glutamic acid decarboxylase activity in human brain. J. Neurochem. 1962, 9:399-401.
24. Napolitano, R., Pariani, G., Fedeli, F., Aswendt, M., Aime, S., Gianolio, E., in press. Synthesis and Relaxometric Characterization of a MRI Gd-based probe responsive to GAD enzymatic activity. Bioconjugate Chem.
25. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982, 1:841-845.
26. Okabe S., Forsberg-Nilsson K., Spiro A.C., Segal M., McKay R.D. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 1996, 59:89-102.
27. Paul S.M. Psychopharmacology: the fourth generation of progress. Drug Development Research 1995, 35:185-188. F.E. Bloom, D.J. Kupfer (Eds.).
28. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
29. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5733-5737.
30. Roberts E., Simonsen D.G. Some properties of l-glutamic decarboxylase in mouse brain. Biochem. Pharmacol. 1963, 12:113-134.
31. Rudelius M., Daldrup-Link H.E., Heinzmann U., Piontek G., Settles M., Link T.M., Schlegel J. Highly efficient paramagnetic labelling of embryonic and neuronal stem cells. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:1038-1044.
32. Saji M., Cohen M., Blau A.D., Wessel T.C., Volpe B.T. Transient forebrain ischemia induces delayed injury in the substantia nigra reticulata: degeneration of GABA neurons, compensatory expression of GAD mRNA. Brain Res. 1994, 643:234-244.
33. Schwartz-Bloom R.D., Sah R. Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia. J. Neurochem. 2001, 77:353-371.
34. Shen J., Cheng L.N., Zhong X.M., Duan X.H., Guo R.M., Hong G.B. Efficient in vitro labeling rabbit neural stem cell with paramagnetic Gd-DTPA and fluorescent substance. Eur. J. Radiol. 2009, 75:397-405.
35. Shin E., Palmer M.J., Li M., Fricker R.A. GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons in vitro, and develop into striatal neurons in vivo in a mouse model of Huntington's disease. Stem Cell Rev. 2011, 767(4). Pages: 333-341.
36. Siemen H., Nix M., Endl E., Koch P., Itskovitz-Eldor J., Brustle O. Nucleofection of human embryonic stem cells. Stem Cells Dev. 2005, 14:378-383.
37. Strijkers G.J., Hak S., Kok M.B., Springer C.S., Nicolay K. Three-compartment T(1) relaxation model for intracellular paramagnetic contrast agents. Magn. Reson. Med. 2009, 61:1049-1058.
38. Terreno E., Geninatti Crich S., Belfiore S., Biancone L., Cabella C., Esposito G., Manazza A.D., Aime S. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn. Reson. Med. 2006, 55:491-497.
39. Walczak P., Ruiz-Cabello J., Kedziorek D.A., Gilad A.A., Lin S., Barnett B., Qin L., Levitsky H., Bulte J.W. Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine 2006, 2:89-94.
40. Willems E., Mateizel I., Kemp C., Cauffman G., Sermon K., Leyns L. Selection of reference genes in mouse embryos and in differentiating human and mouse ES cells. Int. J. Dev. Biol. 2006, 50:627-635.
41. Yoo B., Pagel M.D. An overview of responsive MRI contrast agents for molecular imaging. Front. Biosci. 2008, 13:1733-1752.